Codeine-Guaifenesin
- Product NDC
- 68071-5173
- 11-digit product format
- 680715173
- Labeler code
- 68071
- Product ID
- 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Codeine Phosphate and Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 10; 100 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-5173-4 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-5173-4 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-5173-4 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Codeine-Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995868 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e691264-d48a-6b48-e053-2995a90a9352 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5173-4 | 2024-06-25 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
| 68071-5173-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5173-4 | Codeine-Guaifenesin | 120 mL in 1 BOTTLE | SOLUTION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5173 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| good sense pain relief | ACETAMINOPHEN | NuCare Pharmaceuticals,Inc. | 3c1f505d-0319-a179-e063-6294a90a0b17 | 2025-08-11 | Warnings | M013 |
| Aspirin | ASPIRIN | PROSTAT FIRST AID | 3bdb9d89-9000-69f9-e063-6294a90a0c97 | 2025-08-08 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Prostat First Aid | 3bdbea6a-3f11-9142-e063-6294a90a20ea | 2025-08-08 | Warnings | M013 |
| Aspi-Cor | ASPIRIN | L.N.K. International, Inc. | 9f919a48-ffd8-49fa-b6fd-ec71cc12e64b | 2025-08-08 | Warnings | M013 |
| Aspirin Low Dose | ASPIRIN | A-S Medication Solutions | 8575ef9d-2eae-412a-a252-82b03f4d5275 | 2025-08-08 | Warnings | M013 |
| Aspirin | ASPIRIN | A-S Medication Solutions | 7a91b1df-8d6d-4205-9822-bc4d800555f7 | 2025-08-08 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Bryant Ranch Prepack | 3d6bf733-800c-420a-a9ab-ae4a26134799 | 2025-08-08 | Warnings | M013 |
| Aspirin | ASPIRIN | A-S Medication Solutions | 44b8c203-37c5-425e-9110-f7eb614f9c2d | 2025-08-08 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION INC | c46688ec-e976-4f76-9265-645f59970ff5 | 2025-08-06 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | P & L Development, LLC | c54ad829-f2e8-4367-b439-af20b0ef8ad2 | 2025-08-06 | Warnings | M013 |
| TYLENOL Regular Strength | ACETAMINOPHEN | Kenvue Brands LLC | 398d8996-b522-a3cd-e063-6394a90ac2c8 | 2025-08-06 | Warnings | M013 |
| Aspirin | ASPIRIN | Marlex Pharmaceuticals Inc. | cc7013ea-cf30-6f59-e053-2a95a90a1148 | 2025-08-05 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Prostat First Aid | 3ba313db-bafe-1947-e063-6294a90a528c | 2025-08-05 | Warnings | M013 |
| MEDIQUE APAP acetaminophen | MEDIQUE APAP ACETAMINOPHEN | HF Acquisition Co LLC, DBA HealthFirst | 3ba5c802-fe5a-e42a-e063-6394a90ae67e | 2025-08-05 | Warnings | M013 |
| meijer EXTRA STRENGTH Pain Relief PM CAPLET | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Meijer, Inc. | 376fed3b-7625-6379-e063-6394a90a188d | 2025-08-05 | Warnings | M013 |
| CAREONE INFANTS ACETAMINOPHEN | ACETAMINOPHEN | Retail Business Services, LLC | b8024ec2-97c6-4aa1-b1dd-894164f48811 | 2025-08-04 | Warnings | M013 |
| Exaprin Plus | ASPIRIN, ACETAMINOPHEN, CAFFEINE | HART Health | 8a9ca680-e6cf-4ee4-8a5f-bd6d7470b848 | 2025-08-04 | Warnings | M013 |
| Aspirin | ASPIRIN | Proficient Rx LP | 2ef0757a-fe5f-47de-906a-a4d47a0d0534 | 2025-08-01 | Warnings | M013 |
| Good Sense Pain Relief | ACETAMINOPHEN | Proficient Rx LP | b4cb4a62-9ef7-4185-8770-e9a806c2fb3f | 2025-08-01 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | AAA Pharmaceutical, Inc. | 36ad21a3-6229-e91b-e063-6394a90a7933 | 2025-07-29 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995868 | codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5173-4 | 68071517304 | 120 mL in 1 BOTTLE (68071-5173-4) | 120 ml | 2020-02-12 | 0000-00-00 | No | No | Current |